Discover Great Companies Discover Great Clients
Companies Salaries Jobs
Jobs |
Jobs Companies Salary Majors

Company Overview

Development Stage

About the Company

九芝堂美科(北京)细胞技术有限公司,由百年药企九芝堂发起的九芝堂雍和启航基金投资设立,注册资本为2亿元,主要从事干细胞和再生医学产品的研发、生产和销售等工作。 九芝堂美科引进了美国Stemedica公司的干细胞技术及制备平台,已在北京大兴区中关村医疗器械园建设符合美国和欧盟cGMP标准的同种异体干细胞生产场地,在保证干细胞安全性和治疗效力的前提下,按照符合美国FDA监管要求的生产流程,实现了干细胞可扩增性,解决了干细胞成药的关键技术问题。 未来我们将围绕干细胞开发出更多优质产品,满足不同消费人群的需求,让更多追求健康和美丽的人受益。

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

honors, qualifications & industry associations

Tags are labelled based on keyword text matching analysis and may be related to the company. For reference only.

Related Industry Tags

Tags are auto-annotated by keyword text matching and may be correlated. For reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 20,000万(元)
Legal Representative: 张全成
Date Established:
Credit Code: 91110115MA01APX196
Registered Address: 北京市大兴区中关村科技园区大兴生物医药产业基地永旺西路26号院4号楼201室

People who follow this company also follow

Competitors (Similar Companies)

手术器械 镊子 外科手术设备 医疗器械
药物研发 新药研发 临床试验 创新药
“A landmark enterprise in the modernization of traditional Chinese medi”
制药/药业 生物制药 生物制剂 医药
“An international biopharmaceutical company driven by innovative techno”
“高端医疗器械研发生产商”
数据服务 大数据 研发 数据标准
文化
咨询 政府项目申报 规划设计 科技项目申报
“Research, development, and production of anti-tumor and surgical medic”
化工/化学 新材料 工程塑料 循环经济
“Biomarker Cloud Platform is the first bioinformatics cloud computing p”

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates